Symtuza - Comprehensive Treatment for HIV-1 Infection in Adults

Image credit: poz.com

What is symtuza?

Symtuza is a prescription medicine that is used without other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults and in children who weigh at least 88 pounds (40 kg) who: when their healthcare provider determines that they meet certain requirements.

Does symtuza work on HIV?

Symtuza is an HIV ARV combination medication. It contains four different medications that work together to prevent HIV from infecting your cells and making copies of itself. Darunavir is a protease inhibitor (PI) and blocks an enzyme HIV needs to make copies of itself. Cobicistat is a booster medication. It doesn't act on HIV.

Is symtuza safe?

The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Symtuza is a prescription drug used to treat HIV in adults and children. Learn about uses, side effects, alternatives, and more.

Is symtuza a generic drug?

Symtuza is available only as a brand-name medication. It’s not currently available in generic form. A generic drug is an exact copy of the active drug in a brand-name medication. Generics usually cost less than brand-name drugs. The Food and Drug Administration (FDA) approves prescription drugs such as Symtuza to treat certain conditions.

What is symtuza used for?

Symtuza is a medication used to treat HIV. It is a combination of antiretroviral drugs in one pill, taken once a day. It combines 800mg darunavir, 200mg emtricitabine and 10mg tenofovir alafenamide, along with 150mg cobicistat, in a yellow tablet. The tablet has ‘JG’ on one side and ‘8121’ on the other side. How does Symtuza work?

What is in symtuza?

Contents of the pack and other information What Symtuza contains The active substances are darunavir, cobicistat, emtricitabine, and tenofovir alafenamide. Each film-coated tablet contains 800 mg darunavir (as ethanolate), 150 mg cobicistat, 200 mg emtricitabine, and 10 mg tenofovir alafenamide (as fumarate).

What should a patient know about symtuza?

PATIENT COUNSELING INFORMATION Advise the patient to read the FDA-approved patient labeling (Patient Information). Instructions for Use Advise patients to take SYMTUZA with food every day on a regular dosing schedule, as missed doses can result in development of resistance.

Is symtuza ® safe?

Studies have shown that SYMTUZA ® is both tolerable and effective for those new to treatment or switching to SYMTUZA ®. Please see full Important Safety Information and Prescribing Information, including Boxed Warning for SYMTUZA ®.

What Is Symtuza

1. https://www.symtuza.com/
2. https://www.aidsmap.com/about-hiv/arv-factsheet/symtuza
3. https://www.healthdirect.gov.au/medicines/brand/amt,1454571000168103/symtuza
4. https://www.drugs.com/symtuza.html
5. https://www.medicine.com/drug/symtuza
6. https://www.medicalnewstoday.com/articles/drugs-symtuza
7. https://www.webmd.com/drugs/2/drug-175665/symtuza-oral/details
8. https://www.goodrx.com/symtuza/what-is
9. https://www.ema.europa.eu/en/medicines/human/EPAR/symtuza

Symtuza Information

1. https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/SYMTUZA-pi.pdf
2. https://www.symtuzahcp.com/dosing
3. https://patient-info.co.uk/symtuza-69788/patient-leaflet